Open channel block of Kv3.1 currents by fluoxetine

Journal of Pharmacological Sciences

Volumn 106, Issue 1, 2008, Pages 38-45

  Min, Ji Sung ^a   Hye, Sook Ahn ^b   Sang, June Hahn ^b   Bok, Hee Choi ^a  

^a Chonbuk National University Medical School   (South Korea)

^b The Catholic University of Korea   (South Korea)

Author keywords

Fluoxetine; Kv3.1; Open channel block; Serotonin reuptake inhibitor; Shaw type K+ channel

Indexed keywords

FLUOXETINE; ION CHANNEL; OPEN CHANNEL BLOCK; SHAW POTASSIUM CHANNEL; UNCLASSIFIED DRUG;

ANIMAL CELL; ARTICLE; BINDING KINETICS; CHO CELL; DRUG INHIBITION; DRUG MECHANISM; IC 50; ION CURRENT; NONHUMAN; PATCH CLAMP; WHOLE CELL;

EID: 38549093981     PISSN: 13478613     EISSN: 13478648     Source Type: Journal    
DOI: 10.1254/jphs.FP0070759     Document Type: Article

References (37)

1. Wong DT, Bymaster FP, Engleman EA. Prozac (fluoxetine, Lilly 110140), the first selective serotonin uptake inhibitor and an antidepressant drug: twenty years since its first publication. Life Sci. 1995;57:411-441.
2. Deak F, Lasztoczi B, Pacher P, Petheo GL, Valeria K, Spat A. Inhibition of voltage-gated calcium channels by fluoxetine in rat hippocampal pyramidal cells. Neuropharmacology. 2000;39:1029-1036.
3. + channels by antidepressant drugs. J Pharmacol Exp Ther. 1998;284:208-214.
4. Rae JL, Rich A, Zamudio AC, Candia OA. Effect of Prozac on whole cell ionic currents in lens and corneal epithelia. Am J Physiol. 1995;269:C250-C256.
5. Choi JS, Hahn SJ, Rhie DJ, Yoon SH, Jo YH, Kim MS. Mechanism of fluoxetine block of cloned voltage-activated potassium channel Kv1.3. J Pharmacol Exp Ther. 1999;291:1-6.
6. Hahn SJ, Choi JS, Rhie DJ, Oh CS, Jo YH, Kim MS. Inhibition by fluoxetine of voltage-activated ion channels in rat PC12 cells. Eur J Pharmacol. 1999;367:113-118.
7. Yeung SY, Millar JA, Mathie A. Inhibition of neuronal KV potassium currents by the antidepressant drug, fluoxetine. Br J Pharmacol. 1999;128:1609-1615.
8. Maertens C, Wei L, Voets T, Droogmans G, Nilius B. Block by fluoxetine of volume-regulated anion channels. Br J Pharmacol. 1999;126:508-514.
9. Garcia-Colunga J, Awad JN, Miledi R. Blockage of muscle and neuronal nicotinic acetylcholine receptors by fluoxetine (Prozac). Proc Natl Acad Sci U S A. 1997;94:2041-2044.
10. Perney TM, Marshall J, Martin KA, Hockfield S, Kaczmarek LK. Expression of the mRNAs for the Kv3.1 potassium channel gene in the adult and developing rat brain. J Neurophysiol. 1992;68:756-766.
11. Wang LY, Gan L, Forsythe ID, Kaczmarek LK. Contribution of the Kv3.1 potassium channel to high-frequency firing in mouse auditory neurones. J Physiol. 1998;509:183-194.
12. Kanemasa T, Gan L, Perney TM, Wang LY, Kaczmarek LK. Electrophysiological and pharmacological characterization of a mammalian Shaw channel expressed in NIH 3T3 fibroblasts. J Neurophysiol. 1995;74:207-217.
13. + channel diversity in the mammalian central nervous system. Proc Natl Acad Sci U S A. 1991;88:3932-3936.
14. + channel in T cells. J Biol Chem. 1992;267:20971-20979.
15. Ried T, Rudy B, Vega-Saenz de Miera E, Lau D, Ward DC, Sen K. Localization of a highly conserved human potassium channel gene (NGK2-KV4; KCNC1) to chromosome 11p15. Genomics. 1993;15:405-411.
16. Hahn SJ, Wang LY, Kaczmarek LK. Inhibition by nystatin of Kv1.3 channels expressed in Chinese hamster ovary cells. Neuropharmacology. 1996;35:895-901.
17. Hamill OP, Marty A, Neher E, Sakmann B, Sigworth FJ. Improved patch-clamp techniques for high-resolution current recording from cells and cell-free membrane patches. Pflugers Arch. 1981;391:85-100.
18. Snyders DJ, Yeola SW. Determinants of antiarrhythmic drug action. Electrostatic and hydrophobic components of block of the human cardiac hKv1.5 channel. Circ Res. 1995;77:575-583.
19. Woodhull AM. Ionic blockage of sodium channels in nerve. J Gen Physiol. 1973;61:687-708.
20. Snyders DJ, Tamkun MM, Bennett PB. A rapidly activating and slowly inactivating potassium channel cloned from human heart. Functional analysis after stable mammalian cell culture expression. J Gen Physiol. 1993;101:513-543.
21. Choi BH, Choi JS, Jeong SW, Hahn SJ, Yoon SH, Jo YH, et al. Direct block by bisindolylmaleimide of rat Kv1.5 expressed in Chinese hamster ovary cells. J Pharmacol Exp Ther. 2000;293:634-640.
22. Valenzuela C, Delpon E, Franqueza L, Gay P, Perez O, Tamargo J, et al. Class III antiarrhythmic effects of zatebradine. Time-, state-, use-, and voltage-dependent block of hKv1.5 channels. Circulation. 1996;94:562-570.
23. Delpon E, Valenzuela C, Gay P, Franqueza L, Snyders DJ, Tamargo J. Block of human cardiac Kv1.5 channels by loratadine: voltage-, time- and use-dependent block at concentrations above therapeutic levels. Cardiovasc Res. 1997;35:341-350.
24. Franqueza L, Valenzuela C, Delpon E, Longobardo M, Caballero R, Tamargo J. Effects of propafenone and 5-hydroxypropafenone on hKv1.5 channels. Br J Pharmacol. 1998;125:969-978.
25. Tytgat J, Maertens C, Daenens P. Effect of fluoxetine on a neuronal, voltage-dependent potassium channel (Kv1.1). Br J Pharmacol. 1997;122:1417-1424.
26. Prendiville S, Gale K. Anticonvulsant effect of fluoxetine on focally evoked limbic motor seizures in rats. Epilepsia. 1993;34:381-384.
27. Wada Y, Shiraishi J, Nakamura M, Hasegawa H. Prolonged but not acute fluoxetine administration produces its inhibitory effect on hippocampal seizures in rats. Psychopharmacology (Berl). 1995;118:305-309.
28. Favale E, Rubino V, Mainardi P, Lunardi G, Albano C. Anticonvulsant effect of fluoxetine in humans. Neurology. 1995;45:1926-1927.
29. Pasini A, Tortorella A, Gale K. The anticonvulsant action of fluoxetine in substantia nigra is dependent upon endogenous serotonin. Brain Res. 1996;724:84-88.
30. Browning RA, Wood AV, Merrill MA, Dailey JW, Jobe PC. Enhancement of the anticonvulsant effect of fluoxetine following blockade of 5-HT1A receptors. Eur J Pharmacol. 1997;336:1-6.
31. Rudy B, Chow A, Lau D, Amarillo Y, Ozaita A, Saganich M, et al. Contributions of Kv3 channels to neuronal excitability. Ann N Y Acad Sci. 1999;868:304-343.
32. + current in projecting neurons from the globus pallidus. J Neurophysiol. 1999;82:1512-1528.
33. + channels in sustained high-frequency firing of fast-spiking neocortical interneurons. J Neurophysiol. 1999;82:2476-2489.
34. Rogawski MA, Porter RJ. Antiepileptic drugs: pharmacological mechanisms and clinical efficacy with consideration of promising developmental stage compounds. Pharmacol Rev. 1990;42:223-286.
35. Macdonald RL, Kelly KM. Antiepileptic drug mechanisms of action. Epilepsia. 1995;36 Suppl 2:S2-S12.
36. Karson CN, Newton JE, Livingston R, Jolly JB, Cooper TB, Sprigg J, et al. Human brain fluoxetine concentrations. J Neuropsychiatry Clin Neurosci. 1993;5:322-329.
37. Komoroski RA, Newton JE, Cardwell D, Sprigg J, Pearce J, Karson CN. In vivo 19F spin relaxation and localized spectroscopy of fluoxetine in human brain. Magn Reson Med. 1994;31:204-211.